Phospholipase C and Protein Kinase C-β 2 Mediate Insulin-like Growth Factor II-dependent Sphingosine Kinase 1 Activation
Overview
Molecular Biology
Authors
Affiliations
We recently reported that IGF-II binding to the IGF-II/mannose-6-phosphate (M6P) receptor activates the ERK1/2 cascade by triggering sphingosine kinase 1 (SK1)-dependent transactivation of G protein-coupled sphingosine 1-phosphate (S1P) receptors. Here, we investigated the mechanism of IGF-II/M6P receptor-dependent sphingosine kinase 1 (SK1) activation in human embryonic kidney 293 cells. Pretreating cells with protein kinase C (PKC) inhibitor, bisindolylmaleimide-I, abolished IGF-II-stimulated translocation of green fluorescent protein (GFP)-tagged SK1 to the plasma membrane and activation of endogenous SK1, implicating PKC as an upstream regulator of SK1. Using confocal microscopy to examine membrane translocation of GFP-tagged PKCα, β1, β2, δ, and ζ, we found that IGF-II induced rapid, transient, and isoform-specific translocation of GFP-PKCβ2 to the plasma membrane. Immunoblotting of endogenous PKC phosphorylation confirmed PKCβ2 activation in response to IGF-II. Similarly, IGF-II stimulation caused persistent membrane translocation of the kinase-deficient GFP-PKCβ2 (K371R) mutant, which does not dissociate from the membrane after translocation. IGF-II stimulation increased diacylglycerol (DAG) levels, the established activator of classical PKC. Interestingly, the polyunsaturated fraction of DAG was increased, indicating involvement of phosphatidyl inositol/phospholipase C (PLC). Pretreating cells with the PLC inhibitor, U73122, attenuated IGF-II-dependent DAG production and PKCβ2 phosphorylation, blocked membrane translocation of the kinase-deficient GFP-PKCβ2 (K371R) mutant, and reduced sphingosine 1-phosphate production, suggesting that PLC/PKCβ2 are upstream regulators of SK1 in the pathway. Taken together, these data provide evidence that activation of PLC and PKCβ2 by the IGF-II/M6P receptor are required for the activation of SK1.
Sukocheva O, Neganova M, Aleksandrova Y, Burcher J, Chugunova E, Fan R Cell Commun Signal. 2024; 22(1):251.
PMID: 38698424 PMC: 11064425. DOI: 10.1186/s12964-024-01626-6.
Shimada Y, Yamashita K, Fukuda I, Aizawa T JCEM Case Rep. 2023; 1(1):luac013.
PMID: 37908273 PMC: 10578367. DOI: 10.1210/jcemcr/luac013.
Ueda N Int J Mol Sci. 2022; 23(7).
PMID: 35409370 PMC: 9000186. DOI: 10.3390/ijms23074010.
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.
Tilak M, Holborn J, New L, Lalonde J, Jones N Int J Mol Sci. 2021; 22(4).
PMID: 33673213 PMC: 7918566. DOI: 10.3390/ijms22041831.
Cholecalciferol (Vitamin D) Reduces Rat Neuropathic Pain by Modulating Opioid Signaling.
Poisbeau P, Aouad M, Gazzo G, Lacaud A, Kemmel V, Landel V Mol Neurobiol. 2019; 56(10):7208-7221.
PMID: 31001801 DOI: 10.1007/s12035-019-1582-6.